Home
Dr Lal Pathlabs Ltd PE Ratio
![Image](/insights/_next/image?url=https%3A%2F%2Fstorage.googleapis.com%2Fassets.cdp.blinkx.in%2FBlinkx_Website%2Ficons%2Fdr-lal-pathlabs-ltd.png&w=128&q=75)
Dr Lal Pathlabs Ltd
NSE: LALPATHLAB
PE
Key Highlights
- The P/E Ratio of Dr Lal Pathlabs Ltd is 53.5 as of 12 Feb 15:30 PM .
- The P/E Ratio of Dr Lal Pathlabs Ltd changed from 51.7 on March 2020 to 52.8 on March 2024 . This represents a CAGR of 0.42% over 5 years.
- The Latest Trading Price of Dr Lal Pathlabs Ltd is ₹ 2668 as of 12 Feb 15:30 .
- The PE Ratio of Healthcare Industry has changed from 35.5 to 62.3 in 5 years. This represents a CAGR of 11.91%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of Healthcare industry is 62.3. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Historical P/E Ratio of Dr Lal Pathlabs Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Dr Lal Pathlabs Ltd
Company Fundamentals for Dr Lal Pathlabs Ltd
![Image](/insights/_next/image?url=https%3A%2F%2Fstorage.googleapis.com%2Fassets.cdp.blinkx.in%2FBlinkx_Website%2Ficons%2Fdr-lal-pathlabs-ltd.png&w=128&q=75)
Dr Lal Pathlabs Ltd
NSE: LALPATHLAB
Share Price
Market Price of Dr Lal Pathlabs Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
12 Feb 2025 | 2668.75 |
11 Feb 2025 | 2711.6 |
10 Feb 2025 | 2775.65 |
07 Feb 2025 | 2810.2 |
06 Feb 2025 | 2801.45 |
05 Feb 2025 | 2792 |
04 Feb 2025 | 2829.7 |
03 Feb 2025 | 2833.85 |
01 Feb 2025 | 2860.6 |
31 Jan 2025 | 2851.65 |
SWOT Analysis Of Dr Lal Pathlabs Ltd
BlinkX Score for Dr Lal Pathlabs Ltd
Asset Value vs Market Value of Dr Lal Pathlabs Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Dr Lal Pathlabs Ltd | 22307 | 53.52 |
Max Healthcare Institute Ltd | 97627 | 92.1 |
Apollo Hospitals Enterprise Ltd | 91651 | 69.9 |
Fortis Healthcare Ltd | 46437 | 58.9 |
Global Health Ltd | 29269 | 57.7 |
Syngene International Ltd | 28562 | 59.8 |
Company | |
---|---|
Dr Lal Pathlabs Ltd | 22307 |
Max Healthcare Institute Ltd | 97627 |
Apollo Hospitals Enterprise Ltd | 91651 |
Fortis Healthcare Ltd | 46437 |
Global Health Ltd | 29269 |
Syngene International Ltd | 28562 |
PE Ratio of Dr Lal Pathlabs Ltd Explained
₹22307
Market cap
₹416
Earnings
53.5X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Healthcare Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Dr Lal Pathlabs Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Dr Lal Pathlabs Ltd
Historical Revenue, EBITDA and Net Profit of Dr Lal Pathlabs Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Dr Lal Pathlabs Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Dr Lal Pathlabs Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Dr Lal Pathlabs Ltd
About Dr Lal Pathlabs Ltd
- Dr Lal PathLabs is among the most trusted diagnostic healthcare service provider in India, offering services through over 5000 diagnostic tests and related healthcare services through a nationwide network of medical laboratory centres.
- Through its integrated, nationwide network, the Company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Presently, the Company is engaged the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations.
Dr Lal Pathlabs Ltd News Hub
Dr Lal Pathlabs allots 93,900 equity shares under ESOP
Dr Lal Pathlabs has allotted 93,900 equity shares under Dr. Lal PathLabs Employee Stock Option Plan,
Read more
13 Aug 24
Board of Dr. Lal PathLabs recommends interim dividend
Dr. Lal PathLabs announced that the Board of Directors of the Company at its meeting held on 7 Augus
Read more
07 Aug 24
Dr Lal Pathlabs consolidated net profit rises 28.81% in the June 2024 quarter
Net profit of Dr Lal Pathlabs rose 28.81% to Rs 106.40 crore in the quarter ended June 2024 as again
Read more
07 Aug 24
Dr Lal PathLabs gains after Q1 PAT rises 29% YoY to Rs 108 cr
Revenue from operations increased 11.26% YoY to Rs 601.9 crore during the quarter. Profit before tax
Read more
07 Aug 24